Streetbeat News

Products Services

ELAN

Elanco has announced that the Environmental Protection Agency (EPA) has completed its multi-year review of the Seresto Flea and Tick Collar, confirming its continued registration. Since its launch in 2013, over 41 million Seresto collars have been sold in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 9:26 pm

AAPL

DIS

NFLX

WBD

Hollywood is experiencing a double strike from the Screen Actors Guild - American Federation of Television and Radio Artists (SAG-AFTRA) and the Writers Guild of America (WGA), causing significant industry disruption. The unions are demanding fair compensation and have expressed concerns over the use of artificial intelligence in scriptwriting. The strikes come as the industry is still recovering from the COVID-19 pandemic. Meanwhile, streaming platforms like Netflix, Apple TV+, HBO/HBO Max, and Hulu are dominating the Emmy Award nominations.

Portfolio Pulse from Michael Cohen

July 13, 2023 | 8:41 pm

PTPI

Petros Pharmaceuticals announced a $15M private placement and provided an update on the progress towards the over-the-counter development of STENDRA.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:32 pm

AZYO

Aziyo Biologics has announced a voluntary recall of its viable bone matrix products that were treated with a product from a single donor lot. The company has not provided any details on the reason for the recall or its potential impact.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:32 pm

GPRE

Green Plains Inc. has entered into a technology collaboration with Equilon Enterprises LLC. The collaboration will allow Green Plains to use Fluid Quip Technologies' precision separation and processing technology (MSC™) in conjunction with Shell Fiber Conversion Technology (SFCT). The terms of the collaboration were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:21 pm

RKLB

Rocket Lab USA has signed a deal with Japanese Earth imaging company Synspective to launch two dedicated Electron missions. This brings the total number of Electron launches contracted by Synspective to six. The three missions are scheduled to begin in late 2023 from Launch Complex 1 in New Zealand.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:17 pm

SLQT

SelectQuote, Inc. (NYSE:SLQT) announced that its full-service medication management pharmacy, SelectRx, has received Patient-Centered Pharmacy Home accreditation from The Compliance Team (TCT), a Medicare-approved accreditation organization. This accreditation validates SelectRx's advanced pharmacy practices for chronically ill patients. Since its launch in 2021, SelectRx has grown from serving 2,000 members to over 45,000 members nationwide.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:16 pm

THRX

Theseus Pharmaceuticals is prioritizing the development of its fourth-generation EGFR inhibitor, THE-349, for EGFR mutant non-small cell lung cancer. The company plans to submit an Investigational New Drug (IND) application for the drug in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:13 pm

THRX

Theseus Pharmaceuticals has announced its decision to discontinue enrollment in its Phase 1/2 study and terminate the development of THE-630 for patients with GIST. The company's CEO expressed disappointment as they believed the therapy could have significant clinical benefits.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:09 pm

VTGN

Vistagen Therapeutics (NASDAQ:VTGN) has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent related to the use of AV-101 for reduction of dyskinesia induced by levodopa, a common treatment for Parkinson's disease. The patent, once granted, will not expire until at least 2034. The U.S. Patent and Trademark Office has already granted a related U.S. patent for Vistagen's AV-101. Preclinical data shows AV-101 significantly reduced levodopa-induced dyskinesias without adverse side effects.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:08 pm